• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

作者信息

Carter Philip, Alifrangis Costi, Cereser Biancastella, Chandrasinghe Pramodh, Del Bel Belluz Lisa, Fotopoulou Christina, Frilling Andreja, Herzog Thomas, Moderau Nina, Tabassum Neha, Krell Jonathan, Stebbing Justin

机构信息

Department of Surgery and Cancer, Imperial College, London, UK.

Department of Oncology, University College Hospital, London, UK.

出版信息

Oncotarget. 2018 Mar 13;9(19):15164. doi: 10.18632/oncotarget.24689.

DOI:10.18632/oncotarget.24689
PMID:29601055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5871107/
Abstract

[This corrects the article DOI: 10.18632/oncotarget.23675.].

摘要

相似文献

1
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.
Oncotarget. 2018 Mar 13;9(19):15164. doi: 10.18632/oncotarget.24689.
2
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.评估肿瘤分子特征以指导晚期女性生殖道恶性肿瘤患者的治疗。
Oncotarget. 2017 Dec 27;9(5):6007-6014. doi: 10.18632/oncotarget.23675. eCollection 2018 Jan 19.
3
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.更正：肿瘤分子谱分析对预测结直肠癌治疗方案的益处。
Oncotarget. 2018 Mar 13;9(19):15165. doi: 10.18632/oncotarget.24690.
4
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
Oncotarget. 2018 Mar 13;9(19):15166. doi: 10.18632/oncotarget.24691.
5
Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy.更正：桦木酸的一种新型衍生物SYK023可抑制肺癌的生长和恶性程度。
Oncotarget. 2019 Nov 5;10(60):6536-6537. doi: 10.18632/oncotarget.27297.
6
Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.更正：靶向包含帽蛋白-1（Caprin-1）和c-Myc信使核糖核酸（mRNA）的核糖核蛋白复合物可抑制小鼠肿瘤生长：一种新型癌靶标的鉴定
Oncotarget. 2019 Aug 6;10(47):4919. doi: 10.18632/oncotarget.27074.
7
Correction: Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.
Oncotarget. 2020 Mar 3;11(9):891-892. doi: 10.18632/oncotarget.27371.
8
Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma.
Oncotarget. 2019 Sep 10;10(52):5492. doi: 10.18632/oncotarget.27197.
9
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.更正2：依维莫司（EVE）与依西美坦（EXE）用于≥65岁晚期乳腺癌患者：EVA研究为临床实践带来的新启示
Oncotarget. 2018 Nov 30;9(94):36720-36721. doi: 10.18632/oncotarget.26431.
10
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.更正：依维莫司（EVE）与依西美坦（EXE）用于年龄≥65岁的晚期乳腺癌患者：EVA研究为临床实践带来的新启示。
Oncotarget. 2018 Oct 2;9(77):34639-34640. doi: 10.18632/oncotarget.26213.